Cargando…
Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era
INTRODUCTION: Emergency department (ED) investigations are time-consuming, mainly because of the turnaround time of laboratory assays. Furthermore, several reports showed that more extended emergency stays during the COVID-19 pandemic increase the likelihood of cross-infection. The introduction of t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800766/ http://dx.doi.org/10.1016/j.acvdsp.2022.10.040 |
_version_ | 1784861351492976640 |
---|---|
author | Laouan Brem, F. Hammam, R. Bazid, Z. Nabila, I. Noha, E.O. |
author_facet | Laouan Brem, F. Hammam, R. Bazid, Z. Nabila, I. Noha, E.O. |
author_sort | Laouan Brem, F. |
collection | PubMed |
description | INTRODUCTION: Emergency department (ED) investigations are time-consuming, mainly because of the turnaround time of laboratory assays. Furthermore, several reports showed that more extended emergency stays during the COVID-19 pandemic increase the likelihood of cross-infection. The introduction of troponin point of care assays with improved analytical precision and rapid availability of results compared to central laboratory testing reduces decision-making time in the ED to rule out AMI. OBJECTIVE: We aimed to compare the diagnostic performance of a troponin I POCT assay with a 10-minute turnaround time and the high sensitivity cardiac troponin (hs-cTn) performed in the laboratory. METHOD: A single-center observational cohort study carried out in adults’ patients presenting with non-traumatic chest pain suggestive of AMI at the ED of a tertiary hospital from Jul 29 to Sept 29, 2020. Troponin concentrations were measured on ED arrival and three (3) hours later with both a POCT assay (i-STAT CTnI; Abbott POC) and laboratory hs-cTnI assay (Architect hs-cTnI c8000). RESULTS: On admission and after 3 hours, both POCT and lab Hs-CTn showed the same sensitivity for diagnosing NSTEMI which was 93.8% and reached 100%. The negative predictive value (NPV) for POC CTnI was significantly higher than that for Lab Hs-Tn at 0 h (96.4% versus 95%). After 3 hours, both POCT and Lab Hs-Tn showed a NPV of 100%. Both assays showed higher AUC at 0 hour (POC TnI: 0.972 vs. lab Hs-Tn: 0.957). At 3 hour, the AUC for POC TnI was 0.996 and Lab Hs-Tn AUC was 0.998. (Fig. 1) The average length of hospital stay was 200 min for POCT vs. 464 min for hs-Lab (P < 0.001). CONCLUSION: The results our preliminary cohort suggest that in chest pain patients, the sensitivity of POC CTnI on admission and 3 hours later was comparable to that of the central lab hs-CTnI for ruling in and ruling out NSTEMI. Furthermore, after 3 hours of presenting to the ED, chest pain is not likely due to NSTEMI in patients with a negative POC CTnI assay. Therefore, patients could be safely discharged from the ED with a short emergency stay. |
format | Online Article Text |
id | pubmed-9800766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Published by Elsevier Masson SAS |
record_format | MEDLINE/PubMed |
spelling | pubmed-98007662022-12-30 Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era Laouan Brem, F. Hammam, R. Bazid, Z. Nabila, I. Noha, E.O. Archives of Cardiovascular Diseases. Supplements 520 INTRODUCTION: Emergency department (ED) investigations are time-consuming, mainly because of the turnaround time of laboratory assays. Furthermore, several reports showed that more extended emergency stays during the COVID-19 pandemic increase the likelihood of cross-infection. The introduction of troponin point of care assays with improved analytical precision and rapid availability of results compared to central laboratory testing reduces decision-making time in the ED to rule out AMI. OBJECTIVE: We aimed to compare the diagnostic performance of a troponin I POCT assay with a 10-minute turnaround time and the high sensitivity cardiac troponin (hs-cTn) performed in the laboratory. METHOD: A single-center observational cohort study carried out in adults’ patients presenting with non-traumatic chest pain suggestive of AMI at the ED of a tertiary hospital from Jul 29 to Sept 29, 2020. Troponin concentrations were measured on ED arrival and three (3) hours later with both a POCT assay (i-STAT CTnI; Abbott POC) and laboratory hs-cTnI assay (Architect hs-cTnI c8000). RESULTS: On admission and after 3 hours, both POCT and lab Hs-CTn showed the same sensitivity for diagnosing NSTEMI which was 93.8% and reached 100%. The negative predictive value (NPV) for POC CTnI was significantly higher than that for Lab Hs-Tn at 0 h (96.4% versus 95%). After 3 hours, both POCT and Lab Hs-Tn showed a NPV of 100%. Both assays showed higher AUC at 0 hour (POC TnI: 0.972 vs. lab Hs-Tn: 0.957). At 3 hour, the AUC for POC TnI was 0.996 and Lab Hs-Tn AUC was 0.998. (Fig. 1) The average length of hospital stay was 200 min for POCT vs. 464 min for hs-Lab (P < 0.001). CONCLUSION: The results our preliminary cohort suggest that in chest pain patients, the sensitivity of POC CTnI on admission and 3 hours later was comparable to that of the central lab hs-CTnI for ruling in and ruling out NSTEMI. Furthermore, after 3 hours of presenting to the ED, chest pain is not likely due to NSTEMI in patients with a negative POC CTnI assay. Therefore, patients could be safely discharged from the ED with a short emergency stay. Published by Elsevier Masson SAS 2023-01 2022-12-30 /pmc/articles/PMC9800766/ http://dx.doi.org/10.1016/j.acvdsp.2022.10.040 Text en Copyright © 2022 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | 520 Laouan Brem, F. Hammam, R. Bazid, Z. Nabila, I. Noha, E.O. Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era |
title | Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era |
title_full | Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era |
title_fullStr | Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era |
title_full_unstemmed | Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era |
title_short | Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era |
title_sort | rapid rule-out of acute myocardial infarction at the emergency department with a troponin point of care testing in the covid-19 era |
topic | 520 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800766/ http://dx.doi.org/10.1016/j.acvdsp.2022.10.040 |
work_keys_str_mv | AT laouanbremf rapidruleoutofacutemyocardialinfarctionattheemergencydepartmentwithatroponinpointofcaretestinginthecovid19era AT hammamr rapidruleoutofacutemyocardialinfarctionattheemergencydepartmentwithatroponinpointofcaretestinginthecovid19era AT bazidz rapidruleoutofacutemyocardialinfarctionattheemergencydepartmentwithatroponinpointofcaretestinginthecovid19era AT nabilai rapidruleoutofacutemyocardialinfarctionattheemergencydepartmentwithatroponinpointofcaretestinginthecovid19era AT nohaeo rapidruleoutofacutemyocardialinfarctionattheemergencydepartmentwithatroponinpointofcaretestinginthecovid19era |